NEW YORK, Jan. 31, 2017 /PRNewswire/ -- The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.
The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.
Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:
Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
Automatic reflex testing, repeat testing, and redilution
Further key findings from the study suggest:
Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.
Read the full report: http://www.reportlinker.com/p04523059-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/coagulation-analyzer-market-analysis-by-product-by-technology-mechanical-electrochemical-by-test-types-aptt-d-dimer-fibrinogen-pt-by-end-use-hospitals-research-institutes--segment-forecasts-2013---2024-300399883.html